Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Monica Oliveira

Physician Assistant Mineola, NY Physician Assistant

NPI 1013261353 CMS profile 11240712

212 Jericho Tpke, Mineola, NY 11501

Open in the dashboard

General payments

$10,495

391 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Monica Oliveira of Mineola, NY is reported in the CMS Open Payments database as having received $10,495 across 391 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,244 63
2024 General $3,507 74
2023 General $1,317 49
2022 General $2,291 120
2021 General $2,137 85

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Monica Oliveira
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Monica Oliveira were reported at $1,244. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Monica Oliveira Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,137 $132 $37–$438 $132
2022 $2,291 $155 $48–$522 $149
2023 $1,317 $167 $52–$557 $160
2024 $3,507 $178 $55–$600 $164
2025 $1,244 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $6,398 215 payments
  2. Boston Scientific Corporation $1,769 75 payments
  3. Biotronik Inc. $932 38 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $254 6 payments
  5. Amgen Inc. $226 6 payments
  6. Novartis Pharmaceuticals Corporation $225 24 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $150 6 payments
  8. Teva Pharmaceuticals USA, Inc. $139 1 payment
  9. Pfizer Inc. $89 5 payments
  10. Janssen Pharmaceuticals, Inc $63 4 payments
  11. Other $252 11 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,091 386 payments
  2. Travel and Lodging $1,404 5 payments
Products named General payments · program years 2021–2025
  1. LINQ II $2,698 46 payments
  2. COBALT DR MRI SURESCAN $1,313 59 payments
  3. Cobalt $678 25 payments
  4. AZURE XT DR MRI SURESCAN $637 34 payments
  5. Acticor 7 VR-T DX $474 17 payments
  6. BioMonitor $393 19 payments
  7. MYCARELINK $342 14 payments
  8. Rivacor $285 13 payments
  9. Solia $285 13 payments
  10. Edora $285 13 payments
  11. Other $4,131 200 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

599

Median for Physician Assistant: 241

Drug cost

$326,383

Median for Physician Assistant: $4,110

Branded share of claims

47.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 154 $215,545
Xarelto Rivaroxaban Brand 96 $105,434
Metoprolol Succinate Generic 100 $1,977
Amiodarone Hcl Generic 39 $1,082
Digoxin Generic 16 $443
Valsartan Generic 11 $393
Sotalol Sotalol Hcl Brand 16 $342
Clopidogrel Clopidogrel Bisulfate Brand 20 $292
Carvedilol Generic 17 $206
Hydrochlorothiazide Generic 22 $142

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$16,901

Medicare's payments for the services billed

Medicare patients

184

Average age 77

Services billed

244

70 women, 114 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 74%
Ischemic heart disease 56%
Heart failure 49%
Arthritis 47%
Diabetes 46%
Chronic kidney disease 36%
Cancer 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
FABRAZYME
  • GENZYME CORPORATION $45
$45 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $19
$19 — —
OPSUMIT
  • Actelion Pharmaceuticals US, Inc. $16
$16 — —
UPTRAVI
  • Actelion Pharmaceuticals US, Inc. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

391 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record